Clinical Trial Update: Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a nasal spray for recurrent glioblastoma and related gliomas has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Glioma
• Glioblastoma
• Gliosarcoma

Snippet

Sponsor: Center Trials & Treatment | Conditions: Recurrent Glioblastoma, Gliosarcoma | Phase 1 | Status: WITHDRAWN